Statements (33)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:estradiol
|
| gptkbp:approvedBy |
gptkb:FDA
1975 |
| gptkbp:ATCCode |
G03CA03
|
| gptkbp:chemicalFormula |
C18H24O2
|
| gptkbp:contraindication |
gptkb:cancer
active thromboembolic disorder undiagnosed vaginal bleeding |
| gptkbp:drugClass |
estrogen
|
| gptkbp:form |
gptkb:butter
gptkb:tablet |
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Estrace
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Warner_Chilcott
|
| gptkbp:pregnancyCategory |
gptkb:X_(US)
|
| gptkbp:prescribes |
gptkb:women
transgender women men (certain cancers) |
| gptkbp:routeOfAdministration |
oral
topical |
| gptkbp:sideEffect |
nausea
headache breast tenderness vaginal bleeding |
| gptkbp:usedFor |
gptkb:cancer
prostate cancer hypoestrogenism menopausal symptoms vaginal atrophy |
| gptkbp:bfsParent |
gptkb:estradiol
|
| gptkbp:bfsLayer |
6
|